Publication
Based on Raman spectroscopy and clinical laboratory tests: Developing a fusion model to predict neoadjuvant therapy response in breast cancer.
Xueyi Chen, Zhenlong Li, Yanjun Li, Zongshun Chen, Jie Song, Hongyu Wu, Shan Liu, Lintao Li, Junjie Li
Translational oncologyOct 1, 2026PMID 42636655doi:10.1016/j.tranon.2026.102988 PMC13542601Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Neoadjuvant therapy (NAT) constitutes a pivotal component of comprehensive breast cancer treatment. Early prediction of NAT efficacy is crucial for personalised treatment and improving patient prognosis. However, effective early prediction methods remain lacking at present. METHODS: A…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Breast Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.